Stroke Trial, Recruiting NCT05113043 Sponsor: Shanghai 6th People's Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05113043
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with an acute ischemic or hemorrhagic stroke (a stroke caused either by a blocked blood vessel or bleeding in the brain)
  • People who were admitted to hospital within 12 hours of their stroke
  • People between the ages of 18 and 45 years old

Who may not be able to join:

  • People with a history of neurological diseases, heart attack, kidney or liver problems, or metabolic diseases
  • People who also have a tumour, inflammatory bowel disease, or other digestive system conditions
  • People who have another serious or life-threatening illness or condition
  • People who have taken antibiotics, probiotics, or prebiotics at any point in the three months before the trial
  • People whose condition worsens significantly or who pass away before stool (faecal) samples can be collected

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lixia Xue, M.D., Ph.D., Shanghai 6th People's Hospital

Phone: 02164369181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai 6th People's Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Modified Rankin Scale scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov